Zobrazeno 1 - 10
of 56
pro vyhledávání: '"Holly A Massett"'
Autor:
Alexandra K. Mitchell, Rebecca Ehrenkranz, Sanne Franzen, Sae H. Han, Mujaahida Shakur, Melissa McGowan, Holly A. Massett
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-12 (2024)
Abstract Overly restrictive clinical trial eligibility criteria can reduce generalizability, slow enrollment, and disproportionately exclude historically underrepresented populations. The eligibility criteria for 196 Alzheimer’s Disease and Related
Externí odkaz:
https://doaj.org/article/e2d9a79a942a442291217aa65484f152
Autor:
Jessica B, Langbaum, Julie, Zissimopoulos, Rhoda, Au, Niranjan, Bose, Chris J, Edgar, Evan, Ehrenberg, Howard, Fillit, Carl V, Hill, Lynne, Hughes, Michael, Irizarry, Sarah, Kremen, Darius, Lakdawalla, Nancy, Lynn, Kristina, Malzbender, Tetsuyuki, Maruyama, Holly A, Massett, Deep, Patel, Desi, Peneva, Eric M, Reiman, Klaus, Romero, Carol, Routledge, Michael W, Weiner, Stacie, Weninger, Paul S, Aisen
Publikováno v:
Alzheimer's & Dementia. 19:696-707
Clinical trials for Alzheimer's disease (AD) are slower to enroll study participants, take longer to complete, and are more expensive than trials in most other therapeutic areas. The recruitment and retention of a large number of qualified, diverse v
Autor:
Channing J. Paller, Erich P. Huang, Thomas Luechtefeld, Holly A. Massett, Christopher C. Williams, Jinxiu Zhao, Amy E. Gravell, Tami Tamashiro, Steven A. Reeves, Gary L. Rosner, Michael A. Carducci, Lawrence Rubinstein, S. Percy Ivy
Publikováno v:
Frontiers in Medicine, Vol 6 (2019)
Experimental therapeutic oncology agents are often combined to circumvent tumor resistance to individual agents. However, most combination trials fail to demonstrate sufficient safety and efficacy to advance to a later phase. This study collected sur
Externí odkaz:
https://doaj.org/article/cd7815f522cd4ad1b572ff59f04dc918
Autor:
Rebecca Anne Roper, Rhea Manohar, Mayra Crespo‐Bellido, Elise Bui, Jeanne Jarvis‐Gibson, Alexandra Mitchell, Holly A Massett, Memi Miscally
Publikováno v:
Alzheimer's & Dementia. 18
Autor:
Holly A Massett, Melissa McGowan, Elizabeth Simoneau, Elise Bui, Jeanne Jarvis‐Gibson, Alexandra Mitchell, Kathryn Rehberg, Memi Miscally
Publikováno v:
Alzheimer's & Dementia. 18
Autor:
Charles A. Kunos, Holly A. Massett, Annette Galassi, Joan L. Walker, Marge J. Good, Luis Báez Díaz, Worta McCaskill-Stevens
Publikováno v:
Frontiers in Oncology, Vol 8 (2018)
Women in the U.S. Commonwealth of Puerto Rico (PR) have a higher age-adjusted incidence rate for uterine cervix cancer than the U.S. mainland as well as substantial access and economic barriers to cancer care. The National Cancer Institute (NCI) fund
Externí odkaz:
https://doaj.org/article/505d0f03efe043d8b8c4a735f9a18b67
Autor:
Panne Burke, Leah Alley, Melissa McGowan, Alexandra K Mitchell, Gerda Gallop-Goodman, Holly A. Massett, Elizabeth Simoneau, Sae H Han
Publikováno v:
Journal of Alzheimer's Disease. 82:107-127
Alzheimer’s disease and Alzheimer’s disease-related dementias (AD/ADRD) disproportionally affect Hispanic and Latino populations, yet Hispanics/Latinos are substantially underrepresented in AD/ADRD clinical research. Diverse inclusion in trials i
Autor:
Michael Montello, Holly A. Massett, Grace Mishkin, James H. Doroshow, Amy E. Gravell, Sae H Han, Jeffrey A. Moscow, Michael Steketee, Jeffrey S. Abrams, Martha Kruhm, S. Percy Ivy, James A. Zwiebel, Barbara Barry
Publikováno v:
Clin Cancer Res
Early drug development for cancer requires broad collaboration and skilled clinical investigators to enable enrollment of patients whose tumors have defined molecular profiles. To respond to these challenges, the National Cancer Institute (NCI) trans
Autor:
Mujaahida Shakur, Holly A Massett, Melissa McGowan, Gerda Gallop‐Goodman, Alexandra K Mitchell, Elizabeth Simoneau, Kathryn Rehberg, Panne Burke, Elise Bui
Publikováno v:
Alzheimer's & Dementia. 17
Publikováno v:
Alzheimer's & Dementia. 17